good point, as much as the timeline set by Nader w
Post# of 148164
I will say that it explains why there have been no real BP partners jumping in. I think the process once an NDA is signed by both parties they potential partner gets access to the data set to see what under the hood. I can guess they saw the trial data collection methods and business practices and said no way to partnering with this crap feast. Its not the drug, its the company packaging that created all the problems. I hope those interested partners now can work with the new mgmt and feel the product is on the right path.